Results 181 to 190 of about 288,395 (355)

Cannabidiol in Anorexia Nervosa: A Double‐Blind Randomized Placebo Controlled Pilot Study to Test Safety, Pharmacokinetics, and Symptom Change

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Anorexia nervosa (AN) is a severe psychiatric disorder marked by an intense fear of gaining weight and persistent body dissatisfaction, both during periods of underweight and after weight restoration. The endocannabinoid system may offer therapeutic benefits, particularly in reducing anxiety.
Neha Sahota, David J. Grelotti, Tyler Nguyen, Walter H. Kaye, Skylar Swindle, Raymond Suhandynata, Spencer Seely, Megan E. Shott, Guido K. W. Frank   +8 more
wiley   +1 more source

Approach to novel functional foods for stress control: 5. Antioxidant activity profiles of antidepressant herbs and their active components

, 2005
Mutsuko Shirai, Yoshichika Kawai, Rintaro Yamanishi, Junji Terao   +3 more
openalex   +2 more sources

Latent Trajectories of Body Mass Index and Depressive Symptoms in Inpatients With Anorexia Nervosa: Predictors and Outcomes

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Inpatient treatment aimed at weight restoration and psychiatric stabilization is often required for individuals with anorexia nervosa (AN). This study aimed to identify distinct trajectories of change in body mass index (BMI) and depressive symptoms during inpatient treatment, examine clinical predictors and outcomes, and test ...
Matteo Martini, Mie Sedoc Jørgensen, Cristiano Dani, Anne Bryde Christensen, Magnus Sjögren, Nadia Micali   +5 more
wiley   +1 more source

Association of pharmacotherapy with all-cause mortality among patients with irritable bowel syndrome. [PDF]

Commun Med (Lond)
Mehravar S, Yeo YH, Pimentel M, Naji P, Ng WH, Burger N, Takakura W, Rezaie A.   +7 more
europepmc   +1 more source

Predictors of antidepressant response: A selective review

, 2004
Seetal Dodd, Michael Berk
openalex   +2 more sources

Personalized Treatment Selection for Digital Eating Disorder Interventions: A Proof‐of‐Concept for the Personalized Advantage Index

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Although a range of evidence‐based treatments for eating disorders exist, treatment response varies substantially. The ability to match individuals to a treatment which they are most likely to benefit from may help improve treatment efficiency and therapeutic outcomes.
Zoe McClure, Matthew Fuller‐Tyszkiewicz, Mariel Messer, Jake Linardon   +3 more
wiley   +1 more source

Selective serotonin reuptake inhibitor and serotonin-norepinephrine reuptake inhibitor use and sexual dysfunction: a pharmacovigilance analysis. [PDF]

Sex Med
Shen M, He L, Chen P, Zhang L, Zeng D, Li Y, Li H.   +6 more
europepmc   +1 more source

EEG-based model and antidepressant response

, 2020
Gustav Nilsonne, Frank E. Harrell
openalex   +1 more source

Antidepressant prescribing [PDF]

British Journal of General Practice, 2010
openaire   +2 more sources

Benchmarking Generative Artificial Intelligence Against Human Judgment in Eating Disorder Case Recognition and Treatment Recommendations

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Generative AI is now used to access eating disorder (ED) information, yet the suitability of its outputs remains unclear. Using two vignettes, we evaluated generative AI's ability to accurately identify ED presentations and recommend appropriate care, while benchmarking its performance against published responses from human samples ...
Jake Linardon, Mariel Messer
wiley   +1 more source